Korsana Biosciences, Inc.
Entry into a Material Definitive Agreement · also 2.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 9.01 · Pharmaceutical Preparations · WALTHAM, MA · event 2026-09-08
Non-accelerated filer · Smaller reporting company · FY2020 revenue $2.3M
“Morgan Life Sciences Private Capital, SR One, Sanofi Ventures, Kalehua Capital, Spruce Street Capital, and other leading investment management firms.”